These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6292078)

  • 1. Adenosine--norepinephrine interactions on cyclic AMP generating system in human tumoral brain slices.
    Caciagli F; Ciccarelli R; Ciancetta S; Di Iorio P; Caciagli P
    Int J Tissue React; 1982; 4(3):233-41. PubMed ID: 6292078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclic adenosine 3',5'-monophosphate levels in guinea-pig cerebral cortex by interaction of alpha adrenergic and adenosine receptor activity.
    Sattin A; Rall TW; Zanella J
    J Pharmacol Exp Ther; 1975 Jan; 192(1):22-32. PubMed ID: 235635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclic AMP content in normal and malignant brain cells.
    Perkins JP; Moore MM; Kalisker A; Su YF
    Adv Cyclic Nucleotide Res; 1975; 5():641-58. PubMed ID: 165690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the cyclic adenosine 3',5'-monophosphate response to catecholamines in rat brain slices after repeated restraint stress.
    Stone EA; Slucky AV; Platt JE; Trullas R
    J Pharmacol Exp Ther; 1985 May; 233(2):382-8. PubMed ID: 2987477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the effect of hormones on the accumulation of cyclic AMP in cultured human astrocytoma cells.
    Clark RB; Su YF; Ortmann R; Cubeddu L; Johnson GL; Perkins JP
    Metabolism; 1975 Mar; 24(3):343-58. PubMed ID: 165356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional difference in responsiveness of norepinephrine-sensitive cyclic AMP-generating systems of rat cerebral cortex with iron-induced epileptic activity.
    Hattori Y; Moriwaki A; Hayashi Y; Hori Y
    J Neurochem; 1990 Feb; 54(2):518-25. PubMed ID: 2153752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a specific adenosine receptor on human lymphocytes.
    Marone G; Plaut M; Lichtenstein LM
    J Immunol; 1978 Dec; 121(6):2153-9. PubMed ID: 214496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-generating systems in rat hippocampal slices.
    Segal M; Greenberger V; Hofstein R
    Brain Res; 1981 Jun; 213(2):351-64. PubMed ID: 6113875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The noradrenergic cyclic AMP generating system in the limbic forebrain: pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics.
    Blumberg JB; Vetulani J; Stawarz RJ; Sulser F
    Eur J Pharmacol; 1976 Jun; 37(2):357-66. PubMed ID: 8317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat.
    Lee EH; Lee CP; Wang HI; Lin WR
    Synapse; 1993 Jun; 14(2):144-53. PubMed ID: 7687386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism.
    Roseboom PH; Klein DC
    Mol Pharmacol; 1995 Mar; 47(3):439-49. PubMed ID: 7700241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid enhancement of cAMP accumulation in rat brain particulate fraction after ischaemia.
    Domańska-Janik K; Pylova S
    Int J Tissue React; 1989; 11(2):73-9. PubMed ID: 2559046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine and histamine potentiate the increases in cyclic adenosine 3':5'-monophosphate elicited by vasoactive intestinal polypeptide in mouse cerebral cortical slices: mediation by alpha 1-adrenergic and H1-histaminergic receptors.
    Magistretti PJ; Schorderet M
    J Neurosci; 1985 Feb; 5(2):362-8. PubMed ID: 2983040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells.
    Wajeman-Chao SA; Lancaster SA; Graf LH; Chambers DA
    J Immunol; 1998 Nov; 161(9):4825-33. PubMed ID: 9794415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells.
    Matsuoka I; Zhou Q; Ishimoto H; Nakanishi H
    Mol Pharmacol; 1995 Apr; 47(4):855-62. PubMed ID: 7723748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Noradrenergic potentiation of neurotransmitter-stimulated cAMP production in rat striatal slices.
    Leblanc GG; Ciaranello RD
    Brain Res; 1984 Feb; 293(1):57-65. PubMed ID: 6322919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons.
    Lu Y; Li Y; Herin GA; Aizenman E; Epstein PM; Rosenberg PA
    Eur J Neurosci; 2004 May; 19(10):2669-81. PubMed ID: 15147301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
    Gonzales RA; Roper LC; Westbrook SL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forskolin and 8-cyclopentyltheophylline synergistically facilitate the neuronal activity in the CA2 area of rat hippocampus via cAMP and non-cAMP cascades.
    Zhang J; Sekino Y; Yuan XH
    Sheng Li Xue Bao; 2006 Oct; 58(5):435-41. PubMed ID: 17041727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.